ARQT - Arcutis Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$42.25
DETAILS
HIGH:
$48.00
LOW:
$38.00
MEDIAN:
$41.50
CONSENSUS:
$42.25
UPSIDE:
32.82%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: ARQT has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.